Navigation

E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta

Stentgraft system for the treatment of aneurysms, dissections and specific lesions of the thoracic aorta.

If you wish to be alerted to developments regarding this technology, including consultations and the release of NICE guidance, please express your interest by send an e-mail to medtech@nice.org.uk for the attention of the topic project manager.

Status: History
Expected date of issue: December 2013
Notification date: July 2010
Topic area:
 

NICE project team

Patient Involvement Lead: Laura Norburn
Analyst: Jo Higgins
Communications Lead: Tonya Gillis
Project manager:

Marlon Hope

Implementation Lead: Alexa Biesty
Top


 

Provisional schedule

Submission Date: 01 November 2010
Topic Selection: 14 October 2010
Draft guidance meeting 18 July 2013
Consultation opens: 14 August 2013
Consultation ends: 12 September 2013
Final guidance meeting: 18 October 2013
Top


 

Stakeholders

NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance in this technology please complete a stakeholder registration & confidentiality form and return to us at medtech@nice.org.uk.

Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.

Top


 

Project history

Date Update
18 December 2013 Guidance issued - MTG16 The E vita open plus for treating complex aneurysms and dissections of the thoracic aorta
14 August 2013

The NICE Medical Technologies Evaluation Programme has undertaken an evaluation of E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta. These consultation documents contain information on the committee's draft recommendations and details on how medical technology evaluations are conducted.

Consultation documents can be found in the guidance consultation folder on the bottom of the page under key documents

Consultation on these documents will open on 14 August 2013 at 9.00am and close on 12 September 2013 at 9.00am. NICE would like to receive comments on these documents from anyone who has an interest in the technology or the disease area in general.

15 March 2013 NICE has now published the scope for evaluating this technology. Please see key documents for more information.
8 February 2013 Following agreement with the sponsor NICE has now started its evaluation of this medical technology.
5 August 2011 NICE's assessment of this medical technology is suspended, pending agreement of a suitable start date for the scoping process with the sponsor (see process guide section 5.2). 
Top


 

Key documents

This page was last updated: 16 December 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.